Economic evaluation of HIV testing options for low-prevalence high-income countries: a systematic review.

Health Economics Review
Olanrewaju MeduKevin Pottie

Abstract

This study reviewed the economic evidence of rapid HIV testing versus conventional HIV testing in low-prevalence high-income countries; evaluated the methodological quality of existing economic evaluations of HIV testing studies; and made recommendations on future economic evaluation directions of HIV testing approaches. A systematic search of selected databases for relevant English language studies published between Jan 1, 2001, and Jan 30, 2019, was conducted. The methodological design quality was assessed using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) and the Drummond tool. We reported the systematic review according to the PRISMA guidelines. Five economic evaluations met the eligibility criteria but varied in comparators, evaluation type, perspective, and design. The methodologic quality of the included studies ranged from medium to high. We found evidence to support the cost-effectiveness of rapid HIV testing approaches in low-prevalence high-income countries. Rapid HIV testing was associated with cost per adjusted life year (QALY), ranging from $42,768 to $90,498. Additionally, regardless of HIV prevalence, rapid HIV testing approaches were the most cost-effective option. There is evidence ...Continue Reading

References

Feb 11, 2005·The New England Journal of Medicine·A David PaltielRochelle P Walensky
Mar 5, 2005·The American Journal of Medicine·Rochelle P WalenskyA David Paltiel
Jun 14, 2005·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Rochelle P WalenskyA David Paltiel
Aug 2, 2005·Medical Care·Michael Drummond, Mark Sculpher
Jun 1, 2006·International Journal of STD & AIDS·C H Dewsnap, A Mcowan
Feb 8, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rochelle P WalenskyA David Paltiel
Sep 5, 2008·PharmacoEconomics·Christopher McCabeAnthony J Culyer
Jan 27, 2009·Public Health Reports·Ram K ShresthaJames D Heffelfinger
Feb 17, 2009·Health Economics, Policy, and Law·Richard CooksonHelen Weatherly
Jul 9, 2010·The Cochrane Database of Systematic Reviews·Moses BateganyaSusan M Kiene
Oct 27, 2010·PloS One·Yazdan YazdanpanahA David Paltiel
Jul 19, 2011·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·David W DowdyBeth Kaplan
Oct 11, 2011·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Eugene G MartinEvan M Cadoff
Jan 10, 2012·Current Opinion in HIV and AIDS·Evan WoodJulio S G Montaner
Feb 15, 2012·Journal of Viral Hepatitis·A C El KhouryH Razavi
Jul 18, 2012·PLoS Medicine·Till BärnighausenNalinee Sangrujee
Sep 14, 2012·Drug and Alcohol Dependence·Bruce R SchackmanRochelle P Walensky
Mar 27, 2013·BMJ : British Medical Journal·Don HusereauUNKNOWN CHEERS Task Force
Mar 30, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Don HusereauUNKNOWN ISPOR Health Economic Evaluation Publication Guidelines-CHEERS Good Reporting Practices Task Force
Jun 29, 2013·AIDS·Julie E MyersBernard M Branson
Oct 1, 2013·The Lancet Infectious Diseases·Bohdan NosykUNKNOWN STOP HIV/AIDS Study Group
Nov 5, 2013·Best Practice & Research. Clinical Gastroenterology·Ron Goeree, Vakaramoko Diaby
Aug 28, 2014·The New England Journal of Medicine·Peter J NeumannMilton C Weinstein
Apr 18, 2015·Bulletin of the World Health Organization·Elliot MarseilleSydney Rosen
Jan 1, 2013·Journal of Market Access & Health Policy·Erpur Adalsteinsson, Mondher Toumi
Oct 25, 2016·Liver International : Official Journal of the International Association for the Study of the Liver·Sasha van KatwykKednapa Thavorn
Nov 9, 2016·AIDS Research and Therapy·Emma Sophia KayMichael J Mugavero
Mar 20, 2018·Annals of Internal Medicine·Sonia SinghH Irene Hall
Aug 14, 2018·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Shuhong WangTracy Merlin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.